Triangle CERSI
Triangle CERSI, established in 2023, is an FDA Center of Excellence in Regulatory Science and Innovation. It aims to accelerate the adoption of emerging scientific approaches for regulatory decision-making. The center fosters collaboration between universities (UNC-CH, Duke, NCSU, NCCU), the FDA, industry, and the public to advance regulatory science. Their research focuses on key areas including technological innovations for regulatory decision-making, solutions for data augmentation and clinical trial modernization, engaging patients and consumers, and initiatives to promote health and resiliency. They leverage expertise in areas like AI, machine learning, digital health, and Bayesian methods to address challenges in drug development, clinical trials, and public health.
Triangle CERSI
Triangle CERSI, established in 2023, is an FDA Center of Excellence in Regulatory Science and Innovation. It aims to accelerate the adoption of emerging scientific approaches for regulatory decision-making. The center fosters collaboration between universities (UNC-CH, Duke, NCSU, NCCU), the FDA, industry, and the public to advance regulatory science. Their research focuses on key areas including technological innovations for regulatory decision-making, solutions for data augmentation and clinical trial modernization, engaging patients and consumers, and initiatives to promote health and resiliency. They leverage expertise in areas like AI, machine learning, digital health, and Bayesian methods to address challenges in drug development, clinical trials, and public health.